Effects of Nanoparticles on Living Organisms 2.0

Dear Colleagues,

This Special Issue aims to examine the effects of nanoparticles on living organisms (human or animal, organs, tissues, and cells). Nanoparticles are used in food, agriculture, drug discovery, and medicine (prevention and diagnosis). For example, in the medical field, it is used as a contrast agent in MRI and PET to reveal the internal structure of blood vessels, organs, and tissues. In the drug discovery field, drugs must be safe and effective, and must be able to be delivered to the target site. Therefore, we need to understand the properties and behavior of nanoparticles. Otherwise, they can cause respiratory and cardiovascular diseases, as well as immunological, inflammatory, and allergic diseases.

Nanoparticles that have adsorbed or absorbed toxic substances, particulate matter (e.g., PM2.5), and inorganic dust in the environment significantly impact living organisms in terms of health effects, exposure, toxicity, and body dynamics and deposition. In the current social discourse, particulate matter is cited as key to the risk of viral infections (SARS-Cov-2 virus: COVID-19) and serious illnesses.

Here, we call for reports on the effects of nanoparticles on living organisms (nanoparticles functionalization, in vitro/in vivo evaluation, 3D models, ADME, toxicity, and biomedical applications, etc.) at the molecular level. Therefore, this Special Issue seeks to publish high-quality articles, including original research, reviews, short communications, and clinical trials.

Dr. Yoshitaka Miyamoto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.